32 results
8-K
EX-2.2
SURF
Surface Oncology, Inc.
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:21am
or sale order or other contract, commitment, agreement, instrument, obligation, arrangement, understanding, undertaking, permit, concession or franchise
DEFM14A
SURF
Surface Oncology, Inc.
26 Jul 23
Proxy related to merger
4:56pm
, joint venture agreement, partnership agreement, merger agreement, or other similar agreement or commitment (other than a confidentiality agreement … agreement or commitment (other than a confidentiality agreement entered into in compliance with the Merger Agreement) contemplating or relating
8-K
EX-99.1
SURF
Surface Oncology, Inc.
3 Jul 23
Report of Independent Registered Public Accounting Firm
4:01pm
for a term loan commitment of $25,000 in three potential tranches: (i) a $7,500 term loan facility funded on November 22, 2019 (the “First Tranche Term … between the commitment date stock price of $2.33 per share and the conversion price of $1.56 per share. The beneficial conversion feature was recorded
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
8:08am
, note, mortgage, indenture, guarantee, license, lease, purchase or sale order or other contract, commitment, agreement, instrument, obligation … or officer of the Company or any of its Subsidiaries.
(f) Neither the Company nor any of its Subsidiaries is a party to, or has any commitment
8-K
EX-2.1
SURF
Surface Oncology, Inc.
16 Jun 23
Coherus to Acquire Surface Oncology
7:45am
material bond, debenture, note, mortgage, indenture, guarantee, license, lease, purchase or sale order or other contract, commitment, agreement, instrument … any commitment to become a party to, any joint venture, off balance sheet partnership or any similar Contract (including any Contract or arrangement
425
dm9qk
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-10.1
z148kxlpcv6l
4 Oct 21
Entry into a Material Definitive Agreement
7:05am
8-K
EX-99.1
5bgnqg7gy jyde
8 Jul 21
Surface Oncology Appoints Denice Torres to Board of Directors
7:05am
8-K
EX-1.1
es7q oy0vv1f688
17 Dec 20
Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program
7:05am